Browsing Tag
IL-15
2 posts
How CLD-401 and RedTail may redefine tumor-localized immune activation in solid tumors
Can RedTail and CLD-401 change solid tumor immunotherapy? Read why Calidi Biotherapeutics, Inc.’s next milestones could reshape the CLDI story.
ImmunityBio (NASDAQ: IBRX) secures Saudi FDA approval for ANKTIVA in BCG-unresponsive bladder cancer
ImmunityBio secures Saudi approval for ANKTIVA in NMIBC. Find out how this reshapes the company’s MENA strategy and immunotherapy ambitions.